Psychedeic-Chronicle-Logo

Suggestions

  • Psychedelic News
  • DMT
  • Ketamine
  • Mescaline
  • Psilocybin
  • CEO INTERVIEWS

Psychedeic-Chronicle-Logo

Psychedelic Chronicle

The Psychedelic Chronicle provides the latest psychedelic news, research findings, informational guides & more from the world of psychedelics.

Our mission is to provide accurate, up-to-date information on psychedelics in a way that is clear, concise and easy to understand. We aim to be the go-to resource for anyone interested in learning about these powerful substances.

Journey-Colab-Announces-Appointment-of-Joel-A-Posener-MD-as-Chief-Medical-Officer Psychedeic-Chronicle-Logo-White
Psychedelic News

Journey Colab Announces Appointment of Joel A. Posener, MD as Chief Medical Officer

Biopharmaceutical company Journey Colab who are working to unlock the science of psychedelics and build a new model for addiction treatment recently

July 20, 2022
MAPS-Launches-Online-Education-Curriculum-Psychedelic-Fundamentals Psychedeic-Chronicle-Logo-White
Psychedelic News

MAPS Launches New Online Education Curriculum ‘Psychedelic Fundamentals’

The first part in the new MAPS Digital Learning initiative is Psychedelic Fundamentals, which introduces those interested in learning to the fundamental

July 15, 2022
Zylorion Announces New U.S. Patent Filing For Novel Second-Generation Psilocybin-Based Compound Psychedeic-Chronicle-Logo-White
Psychedelic News

Zylorion Announces New U.S. Patent Filing For Novel Second-Generation Psilocybin-Based Compound

Zylorion announced today the filing of the Company’s third provisional patent application with the United States Patent and Trademark Office (“USPTO”). The

July 14, 2022
Ketamine Wellness Centers KWC Launches New Directory of Ketamine Therapists Psychedeic-Chronicle-Logo-White
Psychedelic News

Ketamine Wellness Centers (KWC) Launches New Directory of Ketamine Therapists

The nation’s largest ketamine therapy provider now offers complimentary patient resources supporting holistic mental health treatment. On Thursday, the largest ketamine therapy

July 1, 2022
Tryp Therapeutics Announces Psilyocbin-Assisted Patent Application for Binge Eating Disorder Treatment Psychedeic-Chronicle-Logo-White
Psychedelic News

Tryp Therapeutics Announces Psilyocbin-Assisted Patent Application for Binge Eating Disorder Treatment

Clinical-stage biotechnology Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF) has strengthened their intellectual property portfolio with a new provisional patent designed to treat

June 30, 2022
Previous 1 2 3

Recent Posts

  • Choose Ketamine Complete Capital Raise to Expand Technology Platform
  • Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax
  • Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment
  • Numinus Develop Psilocybin Mushroom Tea Bags for Psychedelic Research Use
  • atai Life Sciences Announce First Subject Dosed in Synthetic DMT Phase 1 Trial

Recent Comments

No comments to show.

Popular

Choose Ketamine Complete Seed Capital Raise to Expand Technology Platform

Choose Ketamine Complete Capital Raise to Expand Technology Platform

In a major milestone for mental health care, Austin-based Choose

Biomind Labs Secure Pre-IND Meeting, Seek FDA Feedback on New Triptax Depression Treatment

Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax

The well-known psychedelic biotech company Biomind Labs Inc. (NEO: BMND)

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma (Nasdaq: SILO), a developmental-stage psychedelic biopharmaceutical firm, announced

Psychedeic-Chronicle-Logo

© 2022 PSYCHEDELIC CHRONICLE
ALL RIGHTS RESERVED.

  • Psychedelic News
  • DMT
  • Ketamine
  • Mescaline
  • Psilocybin
  • CEO INTERVIEWS